PXS-5505A

N/A

Report date: 2023/01/01 10:23:23
NME

Base Information

Drug NamePXS-5505A
Drug Alias NamePXS-5505A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysyl oxidase inhibitors
TargetsLysyl oxidase
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSyntara Ltd
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A